91 related articles for article (PubMed ID: 11693821)
1. Diagnosis of thyroid cancer and cytogenetics.
Antonaci A; Boncompagni A; De Capoa A; Consorti F; Giovannone G; Mardente S; Vietri F
Tumori; 2001; 87(4):S46-8. PubMed ID: 11693821
[No Abstract] [Full Text] [Related]
2. The expression of PAX8-PPARgamma rearrangements is not specific to follicular thyroid carcinoma.
Nakabashi CC; Guimarães GS; Michaluart P; Ward LS; Cerutti JM; Maciel RM
Clin Endocrinol (Oxf); 2004 Aug; 61(2):280-2. PubMed ID: 15272927
[No Abstract] [Full Text] [Related]
3. Transcriptional activation of the bcl-2 apoptosis suppressor gene by the paired box transcription factor PAX8.
Hewitt SM; Hamada S; Monarres A; Kottical LV; Saunders GF; McDonnell TJ
Anticancer Res; 1997; 17(5A):3211-5. PubMed ID: 9413150
[TBL] [Abstract][Full Text] [Related]
4. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR(gamma) fusion oncogene.
Lui WO; Foukakis T; Lidén J; Thoppe SR; Dwight T; Höög A; Zedenius J; Wallin G; Reimers M; Larsson C
Oncogene; 2005 Feb; 24(8):1467-76. PubMed ID: 15608688
[TBL] [Abstract][Full Text] [Related]
6. [Oncogenes and thyroid tumors].
Lacroix L; Soria JC; Bidart JM; Schlumberger M
Bull Cancer; 2005 Jan; 92(1):37-43. PubMed ID: 15689324
[TBL] [Abstract][Full Text] [Related]
7. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
Marques AR; Espadinha C; Catarino AL; Moniz S; Pereira T; Sobrinho LG; Leite V
J Clin Endocrinol Metab; 2002 Aug; 87(8):3947-52. PubMed ID: 12161538
[TBL] [Abstract][Full Text] [Related]
8. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.
Cheung L; Messina M; Gill A; Clarkson A; Learoyd D; Delbridge L; Wentworth J; Philips J; Clifton-Bligh R; Robinson BG
J Clin Endocrinol Metab; 2003 Jan; 88(1):354-7. PubMed ID: 12519876
[TBL] [Abstract][Full Text] [Related]
9. Functional interaction among thyroid-specific transcription factors: Pax8 regulates the activity of Hex promoter.
Puppin C; Presta I; D'Elia AV; Tell G; Arturi F; Russo D; Filetti S; Damante G
Mol Cell Endocrinol; 2004 Feb; 214(1-2):117-25. PubMed ID: 15062550
[TBL] [Abstract][Full Text] [Related]
10. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
Nikiforova MN; Lynch RA; Biddinger PW; Alexander EK; Dorn GW; Tallini G; Kroll TG; Nikiforov YE
J Clin Endocrinol Metab; 2003 May; 88(5):2318-26. PubMed ID: 12727991
[TBL] [Abstract][Full Text] [Related]
11. Thyroid defects due to Pax8 gene mutations.
Damante G
Eur J Endocrinol; 1998 Dec; 139(6):563-6. PubMed ID: 9916856
[No Abstract] [Full Text] [Related]
12. Human thyroid cancer cells as a source of iso-genic, iso-phenotypic cell lines with or without functional p53.
Wyllie FS; Haughton MF; Rowson JM; Wynford-Thomas D
Br J Cancer; 1999 Mar; 79(7-8):1111-20. PubMed ID: 10098744
[TBL] [Abstract][Full Text] [Related]
13. Reexpression of thyroid peroxidase in a derivative of an undifferentiated thyroid carcinoma cell line by introduction of wild-type p53.
Fagin JA; Tang SH; Zeki K; Di Lauro R; Fusco A; Gonsky R
Cancer Res; 1996 Feb; 56(4):765-71. PubMed ID: 8631011
[TBL] [Abstract][Full Text] [Related]
14. A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation.
Castro P; Roque L; Magalhães J; Sobrinho-Simões M
Int J Surg Pathol; 2005 Jul; 13(3):235-8. PubMed ID: 16086077
[TBL] [Abstract][Full Text] [Related]
15. [Gene abnormalities in thyroid cancer].
Namba H; Yamashita S
Nihon Rinsho; 2007 Nov; 65(11):1967-72. PubMed ID: 18018556
[TBL] [Abstract][Full Text] [Related]
16. The molecular basis of thyroid epithelial tumorigenesis.
Bongarzone I; Pierotti MA
Tumori; 2003; 89(5):514-6. PubMed ID: 14870774
[TBL] [Abstract][Full Text] [Related]
17. Thyroid transcription factor 1 rescues PAX8/p300 synergism impaired by a natural PAX8 paired domain mutation with dominant negative activity.
Grasberger H; Ringkananont U; Lefrancois P; Abramowicz M; Vassart G; Refetoff S
Mol Endocrinol; 2005 Jul; 19(7):1779-91. PubMed ID: 15718293
[TBL] [Abstract][Full Text] [Related]
18. A thyroid-specific far-upstream enhancer in the human sodium/iodide symporter gene requires Pax-8 binding and cyclic adenosine 3',5'-monophosphate response element-like sequence binding proteins for full activity and is differentially regulated in normal and thyroid cancer cells.
Taki K; Kogai T; Kanamoto Y; Hershman JM; Brent GA
Mol Endocrinol; 2002 Oct; 16(10):2266-82. PubMed ID: 12351692
[TBL] [Abstract][Full Text] [Related]
19. PPARgamma staining as a surrogate for PAX8/PPARgamma fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic value.
Sahin M; Allard BL; Yates M; Powell JG; Wang XL; Hay ID; Zhao Y; Goellner JR; Sebo TJ; Grebe SK; Eberhardt NL; McIver B
J Clin Endocrinol Metab; 2005 Jan; 90(1):463-8. PubMed ID: 15483076
[TBL] [Abstract][Full Text] [Related]
20. Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival.
Muratovska A; Zhou C; He S; Goodyer P; Eccles MR
Oncogene; 2003 Sep; 22(39):7989-97. PubMed ID: 12970747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
